Brighton Jones’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
Other funds holding CHRS
TGY2IT
CM
Brighton Jones's CHRS Position: Q3 2026 in Review
Brighton Jones sold out of Coherus Oncology (CHRS) in Q3 2026, closing a stake of 12,803 shares — an estimated $17.9K sold.
Brighton Jones first reported a position in CHRS in Q2 2026 and held it in 1 quarter. The position peaked at $17.9K in Q2 2026. 134 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.
- Brighton Jones reported no remaining Coherus Oncology position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 12,803 Coherus Oncology shares in Q3 2026, an estimated $17.9K.
- Brighton Jones first reported a position in Coherus Oncology in Q2 2026 and held it in 1 quarter.
- Brighton Jones's Coherus Oncology position peaked at $17.9K in Q2 2026.
- 134 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.